Navigation Links
New Productivity Suite From Varian, Inc. Increases Throughput for NMR Laboratories
Date:9/21/2009

PALO ALTO, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today a suite of new products to enhance the flexibility and automated use of its 400-MR Nuclear Magnetic Resonance (NMR) system. The collection of new tools comprises the OneNMR(TM) probe, a choice of two autosamplers, and an easy to use, customer-centric software package. Designed with enhanced sample throughput and streamlined data management in mind, each piece can improve laboratory workflows on its own. Implemented as a complete package, these new products provide unmatched productivity for routine chemical applications in pharmaceutical, biotech, chemical and academic environments.

The 400 MHz OneNMR(TM) probe represents a significant design breakthrough combining the performance advantages of both direct (carbon) and indirect (proton) detection in a single multi-use probe. The probe is available in two versions. One version can be tuned manually or automatically with ProTune(TM). The second version incorporates a new 3rd generation piezoelectric (Protune-PZT) tuning module. The new probes eliminate time consuming probe changes, significantly enhancing system uptime and overall productivity.

The 7510-AS (12-sample) and 7600-AS (96-sample) autosamplers increase system efficiency by eliminating idle time between runs and enable users to extend the workday with unattended operation. Both systems were designed and built to provide for extended, maintenance-free operation.

The all-new VnmrJ 3.0 software drives the system and is designed for multi-user, walk-up and high-throughput customers alike. With its sample-centric data management structure and intuitive user interface, the package provides for queuing of multiple samples yet provides the flexibility for interrupting operation in the case of priority samples.

"Integrating the automation package with the 40
'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
2. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
3. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
4. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
5. DuPont Partnering with China to Increase Farm Productivity
6. DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy
7. Increasing Sales Productivity Through Superior Sales Force Performance Management
8. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
9. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire/--PearlTherapeuticsInc.,abiophar...hetreatmentofchronicrespiratorydiseases,todayannou...fDirectors.Mr.Rosenhas25yearsofexperienceinthephar...olesatGileadSciencesandALZACorporation.Hisappointm...x. ,, "Howiebringsawealthofproductdevelopment,c...
(Date:11/20/2009)...0 Dendreon Corporation (... and Drug Administration (FDA) provided written ac... License Application (BLA) for PROVENGE® (sip...signed a Prescription Drug User Fee Act (PDUFA) da...o Dendreon,s amended BLA. Dendreon is seeking lic...
(Date:11/20/2009)...ETTLER TOLEDO recently announced that Dr. Dominiqu... Role of Process Analytical Technology (PAT) in Gr...mber 1, 2009. , (PRWEB) N...s Analytical Technology (PAT) in Green Chemistry a...ss Analytical Technology (PAT) case studies will b...
(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...usly reported $6.3 million registered direct place...s of its common stock and warrants to purchase up ...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...ent, BASEL, Switzerland and TUCSON, Ariz., Jan. 2...d-leading healthcare,provider of pharmaceuticals a...ana") (Nasdaq: VMSI ) today announced that they h...e terms of the agreement, Roche will,increase the ...mon shares,to $89.50 per share in cash (or an aggr...
...x,Orthobiology B.V. announced today the closure of...y BioGeneration Ventures., Progentix Orthobiology...e suite of osteoinductive material products for cl...rogentix bone graft material is based on,surface s...the ability to,attract growth factors and stems ce...
...s,announced that it will continue to provide Avast...thalmologists who request it for their patients.,T..., Genentech,s, decision,( http://www.lucentis.com/...Avastin directly to compounding pharmacies as of J...tinal specialists and,ophthalmologists to treat ag...
Other Biology Technology:Roche to Acquire Ventana for $89.50 per share 2Roche to Acquire Ventana for $89.50 per share 3Roche to Acquire Ventana for $89.50 per share 4Roche to Acquire Ventana for $89.50 per share 5Roche to Acquire Ventana for $89.50 per share 6Progentix Orthobiology B.V. Closes Series A Financing Round 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 3
(Date:11/23/2009)... , Sewer overflows are a nasty business, posing d...Carolina State University is launching a new proje...tion Agency (EPA) that targets the fat and grease ...r, and will give urban planners new tools to furth...are overflows from "sanitary" sewer systems, as op...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
(Date:11/22/2009)... , A commonly inherited gene deletion can increas... bone marrow transplantation, an international tea...e online issue of Nature Genetics . When the gene...me but present in the recipient,s, transplants hav...ffect known as graft-versus-host disease, in which...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 1BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 2Reverse Ages Staying Young Naturally 50696 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 5
...ctors from different hospitals can collaborate on ...rating room. What if doctors in remote locations c...cialists in hospitals around the world? , This en...search by a multi-university partnership that is t...dvanced networking consortium Internet2. , Roche...
...g is causing the worldwide declines of amphibians ...cording to biologists. The findings, which contrad...is killing the frogs and toads and aid in their co... sixth mass extinction event," said Peter Hudson, ...d co-author of the research study. "And amphibians...
...matodes are extreme parasites. These microscopic, ...ral and field crops in sub-tropical regions, resul...d gardeners. , Until recently, fumigation of the ...rimary method for controlling root-knot nematodes ... is an odorless, colorless gas that has been widel...
Other Biology News:The next step in health care: Telemedicine 2Global warming link to amphibian declines in doubt 2Global warming link to amphibian declines in doubt 3Parasite-resistant peppers green alternatives to chemical pesticides 2
Eosinophil Chip-IHC from 3H Biomedical AB
B Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
Biology Products: